ALZN (STOCKS)
Alzamend Neuro, Inc. Common Stock
$1.455000
+0.015000 (+1.04%)
Prev close: $1.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Stephan Jackman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7.52M
- Employees
- 7
- P/E (TTM)
- -0.50
- P/B (TTM)
- 8.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$5.54K |
| Operating Expenses | $8.77M |
| Research and Development | $3.63M |
| Other Operating Expenses | $5.14M |
| Operating Income/Loss | -$8.77M |
| Income/Loss From Continuing Operations After Tax | -$8.77M |
| Income/Loss From Continuing Operations Before Tax | -$8.77M |
| Interest Expense, Operating | $6.62K |
| Net Income/Loss | $8.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $17.57M |
| Net Income/Loss Attributable To Parent | -$8.77M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.77M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.63 |
| Diluted Earnings Per Share | -$2.63 |
| Basic Average Shares | 3,337,143 |
| Diluted Average Shares | 3,337,143 |
| Assets | $2.08M |
| Current Assets | $1.76M |
| Noncurrent Assets | $314.87K |
| Fixed Assets | $314.87K |
| Liabilities | $1.35M |
| Current Liabilities | $1.35M |
| Noncurrent Liabilities | $0.00 |
| Equity | $733.21K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $733.21K |
| Liabilities And Equity | $2.08M |
| Net Cash Flow From Operating Activities | -$8.07M |
| Net Cash Flow From Operating Activities, Continuing | -$8.07M |
| Net Cash Flow From Investing Activities | $3.24M |
| Net Cash Flow From Investing Activities, Continuing | $3.24M |
| Net Cash Flow From Financing Activities | $4.83M |
| Net Cash Flow From Financing Activities, Continuing | $4.83M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | $8.80M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $8.80M |
| Other Comprehensive Income/Loss | $0.00 |